Clomipramine Treatment of Obsessive-Compulsive Disorder: II. Biochemical Aspects
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Concentrations of the serotonin metabolite 5-hydroxyindoleacetic acid (5-HIAA), the dopamine metabolite homovanillic acid, and the noradrenaline metabolite 4-hydroxy-3-methoxyphenyl glycol were measured in CSF before and after three weeks' treatment of severe obsessive-compulsive disorder with clomipramine hydrochloride. Patients who responded to clomipramine treatment had significantly higher CSF levels of 5-HIAA before treatment. The amelioration of obsessive-compulsive symptoms was positively correlated to the reduction of CSF concentrations of 5-HIAA during clomipramine treatment but negatively correlated to plasma concentrations of clomipramine. Reduction of CSF concentrations of 5-HIAA, which probably reflects drug action on central serotonin neurons, was maximal at a plasma clomipramine concentration of about 300 nmole/L. At higher levels, the reduction of CSF levels of 5-HIAA was smaller. The antiobsessive effect of clomipramine may be connected to its capacity to inhibit serotonin uptake.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
"Serotonin Depression"—A Biochemical Subgroup Within the Affective Disorders?
Åsberg, M., Thorén, P., Traskman, L., Bertilsson, L., & Ringberger, V. (1976) · Science · doi:10.1126/science.1246632 · Cited by 682
Self-citationCarlsson, A., Corrodi, H., Fuxe, K., & Hökfelt, T. (1969) · European Journal of Pharmacology · doi:10.1016/0014-2999(69)90113-7 · Cited by 643
Åsberg, M., Bertilsson, L., Tuck, D., Cronholm, B., & Sjoqvist, F. (1973) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1973142277 · Cited by 242
van Praag, H. M., & Korf, J. (1971) · Psychopharmacologia · doi:10.1007/bf00402638 · Cited by 225
Plasma levels of chlorimipramine and its demethyl metabolite during treatment of depression
Träskman, L., Åsberg, M., Bertiisson, L., Cronholm, B., Mellström, B., Neckers, L. Μ., Sjöqvist, F., Thorén, P., & Tybring, G. (1979) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1979265600 · Cited by 142
Self-citationBertilsson, L., Atkinson, A. J., Althaus, J. R., Harfast, A., Lindgren, J. E., & Holmstedt, B. R. (1972) · Analytical Chemistry · doi:10.1021/ac60316a056 · Cited by 106
Åsberg, M., Ringberger, V.-A., Sjöqvist, F., Thorén, P., Träskman, L., & Tuck, J. R. (1977) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1977212201 · Cited by 92
Self-citationFuxé, K., Ögren, S. O., Agnati, L. F., Gustafsson, J. Å., & JONSSON, G. (1977) · Neuroscience Letters · doi:10.1016/0304-3940(77)90095-7 · Cited by 91
Bertilsson, L., �sberg, M., & Thor�n, P. (1974) · European Journal of Clinical Pharmacology · doi:10.1007/bf00558208 · Cited by 90
Self-citationMuscettola, G., Goodwin, F. K., Potter, W. Z., Claeys, M. M., & Markey, S. P. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770290103009 · Cited by 73
Cited by
Reconciling the role of central serotonin neurons in human and animal behavior
Soubrié, P. (1986) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00022871 · Cited by 996
Baxter, L. R. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800150017003 · Cited by 860
Monoamine Metabolites in CSF and Suicidal Behavior
Träskman, L. (1981) · Archives of General Psychiatry · doi:10.1001/archpsyc.1981.01780310031002 · Cited by 689
Wong, D. T., Bymaster, F. P., & Engleman, E. A. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00209-o · Cited by 647
Benkelfat, C. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810210048007 · Cited by 539
Clomipramine Treatment of Childhood Obsessive-Compulsive Disorder: A Double-blind Controlled Study
Flament, M. F. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790330057007 · Cited by 466
Lust, attraction, and attachment in mammalian reproduction
Fisher, H. E. (1998) · Human Nature · doi:10.1007/s12110-998-1010-5 · Cited by 429
Zohar, J., & Insel, T. R. (1987) · Biological Psychiatry · doi:10.1016/0006-3223(87)90199-5 · Cited by 416
Kruesi, M. J. P. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810170019003 · Cited by 412
Efficacy of Fluvoxamine in Obsessive-Compulsive Disorder: A Double-blind Comparison With Placebo
Goodman, W. K. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810010038006 · Cited by 390
Zohar, J. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800230026006 · Cited by 370
Stein, D. J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09620-4 · Cited by 352
Glutamatergic Dysfunction in OCD
Chakrabarty, K., Bhattacharyya, S., Christopher, R., & Khanna, S. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300733 · Cited by 344
Obsessive-compulsive disorder and serotonin: Is there a connection?
Insel, T. R., Mueller, E. A., Alterman, I., Linnoila, M., & Murphy, D. L. (1985) · Biological Psychiatry · doi:10.1016/0006-3223(85)90176-3 · Cited by 343
Obsessive-Compulsive Disorder: A Double-blind Trial of Clomipramine and Clorgyline
Insel, T. R. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.04390010015002 · Cited by 343
Defining the Brain Systems of Lust, Romantic Attraction, and Attachment
Fisher, H. E., Aron, A., Mashek, D., Li, H., & Brown, L. L. (2002) · Archives of Sexual Behavior · doi:10.1023/a:1019888024255 · Cited by 317
Zohar, J. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800260081011 · Cited by 294
CSF monoamine metabolites in melancholia
Åsberg, M., Bertilsson, L., Mårtensson, B., Scalia‐Tomba, G. ‐., Thorén, P., & Träskman‐Bendz, L. (1984) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1984.tb02488.x · Cited by 289
Self-citationNeurotransmitters and Suicidal Behavior: The Evidence from Cerebrospinal Fluid Studiesa
ÅSBERG, M. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb52359.x · Cited by 285
(1988) · American Journal of Psychiatry · doi:10.1176/ajp.145.9.1089 · Cited by 284
Kaye, W. H. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810300068010 · Cited by 279
(1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.3.363 · Cited by 276
Hollander, E. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820010021003 · Cited by 268
Serotonin and anxiety revisited
Kahn, R. S., van Praag, H. M., Wetzler, S., Asnis, G. M., & Barr, G. (1988) · Biological Psychiatry · doi:10.1016/0006-3223(88)90091-1 · Cited by 258
Controlled trial of exposure and response prevention in obsessive–compulsive disorder
Lindsay, M., Crino, R., & Andrews, G. (1997) · British Journal of Psychiatry · doi:10.1192/bjp.171.2.135 · Cited by 245
Leckman, J. F. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950100030003 · Cited by 209
Low level of dopaminergic D2 receptor binding in obsessive-compulsive disorder
Denys, D., van der Wee, N., Janssen, J., De Geus, F., & Westenberg, H. G. M. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.01.023 · Cited by 195
Leckman, J. F., Goodman, W. K., Anderson, G. M., Riddle, M. A., Chappell, P. B., McSwiggan-Hardin, M. T., McDougle, C. J., Scahill, L. D., Ort, S. I., Pauls, D. L., et al. (1995) · Neuropsychopharmacology · doi:10.1038/sj.npp.1380241 · Cited by 169
Neurobiology of Obsessive-Compulsive Disorder:Serotonin and Beyond
Westenberg, H. G. M., Fineberg, N. A., & Denys, D. (2007) · CNS Spectrums · doi:10.1017/s1092852900002479 · Cited by 148
Compulsive behavior in the 5-HT2C receptor knockout mouse
Chou-Green, J. M., Holscher, T. D., Dallman, M. F., & Akana, S. F. (2003) · Physiology & Behavior · doi:10.1016/s0031-9384(03)00047-7 · Cited by 143
“had increased cerebrospinal fluid levels of the 5-HT metabolite 5-hydroxyindoleactic acid (5-HIAA), and treatment response was correlated with reductions in 5-HIAA and platelet 5-HT levels [4].”
BackgroundThe current status of association studies in obsessive-compulsive disorder
Hemmings, S. M. J., & Stein, D. J. (2006) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2006.02.011 · Cited by 83
Wood, J., LaPalombara, Z., & Ahmari, S. E. (2018) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2017.0023 · Cited by 41
Plasma catecholamines and their metabolites in obsessive-compulsive disorder
Benkelfat, C., Mefford, I. N., Masters, C. F., Nordahl, T. E., King, A. C., Cohen, R. M., & Murphy, D. L. (1991) · Psychiatry Research · doi:10.1016/0165-1781(91)90067-y · Cited by 30
Ruiz (2000) · doi:10.1097/00131746-200005000-00002 · Cited by 14
Metadata
- Authors
- Thorän, P.
- Venue
- Archives of General Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 1980-11-01
- Volume
- 37
- Issue
- 11
- Pages
- 1289
- ISSN
- 0003-990X (ISSN-L)
- OpenAlex
- W2105500530
- Cited by
- 289
- References
- 16
- FWCI
- 8.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.